Your body needs time to adjust to each: GLP-1 receptor: Slows gastric emptying, reduces appetite GIP receptor: Enhances insulin signaling, affects fat metabolism Glucagon receptor: Increases energy expenditure, promotes fat oxidation Jumping to high doses overwhelms these systems, causing: Severe nausea and vomiting Treatment discontinuation Longer overall time to reach therapeutic doses The data: In the Phase 2 NEJM study, participants who started at 4 mg instead of 2 mg had significantly higher rates of gastrointestinal side effects
Symptoms can be mild, moderate, or severe
Visual inspection can detect some damage
GLP-1 Agonists and Their Impact on Thermoregulation: A Review, Endocrinology Reports
Recognising and Managing Yeast Infections Yeast infections , most commonly caused by Candida albicans , can affect various parts of the body, but vulvovaginal candidiasis in women and balanitis (inflammation of the glans penis) in men are the most frequent presentations